National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings, 44166-44167 [07-3848]
Download as PDF
<![CDATA[
44166
Federal Register / Vol. 72, No. 151 / Tuesday, August 7, 2007 / Notices
TABLE 2.—ANNUALIZED COST TO RESPONDENTS
Number of
respondents
Type of respondents
Response frequency
Approx. hourly
wage rate
Total respondent cost**
Applicants ........................................................................................................
Extramural evaluators ......................................................................................
1200
220
1
1
$55.00
55.00
$8,250
1,512.50
Total ..........................................................................................................
710
1
55.00
9,662.50
**Total Respondent Cost = N Respondents * Response Frequency * minutes to complete/60 * hourly rate.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information, including the validity of
the methodology and assumptions used;
(3) ways to enhance the quality, utility,
and clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact G. Stephane
Philogene, PhD, Assistant Director for
Policy and Planning, Office of
Behavioral and Social Sciences
Research, National Institutes of Health,
31 Center Drive. Building 31, Room B2–
B37 Bethesda, MD 20892, or call nontoll-free number 301–402–3902, or Email your request, including your
address to: philoges@od.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60-days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT:
Dated: July 31, 2007.
G. Stephane Philogene,
Assistant Director for Policy and Planning,
Office of Behavioral and Social Sciences
Research, National Institutes of Health.
[FR Doc. E7–15350 Filed 8–6–07; 8:45 am]
jlentini on PROD1PC65 with NOTICES
BILLING CODE 4140–01–P
VerDate Aug<31>2005
15:56 Aug 06, 2007
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Establishment
Pursuant to the Federal Advisory
Committee Act, as amended (5 U.S.C.
Appendix 2), the Director, National
Institutes of Health (NIH), announces
the establishment of the Interagency
Autism Coordinating Committee
(Committee).
The Committee shall coordinate all
efforts within the Department of Health
and Human Services concerning autism
spectrum disorder to combat autism
through research, screening,
intervention and education. The
Committee’s primary mission is to
facilitate the efficient and effective
exchange of information on autism
activities among the member agencies,
and to coordinate autism-related
programs and initiatives. The
Committee will serve as a forum and
assist in increasing public
understanding of the member agencies’
activities, programs, policies, and
research, and in bringing important
matters of interest forward for
discussion.
Duration of this committee is two
years from the date the Charter is filed.
Dated: July 31, 2007.
Elias Zerhouni,
Director, National Institutes of Health.
[FR Doc. 07–3850 Filed 8–6–07; 8:45 am]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Weight Control Clinical Trial.
Date: September 14, 2007.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Dr., Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Youngsuk Oh, Scientific
Review Administrator, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7182,
Bethesda, MD 20892–7924, 301–435–0277,
yoh@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: July 31, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–3847 Filed 8–6–07; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meetings of the
National Diabetes and Digestive and
Kidney Diseases Advisory Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
E:\FR\FM\07AUN1.SGM
07AUN1
Federal Register / Vol. 72, No. 151 / Tuesday, August 7, 2007 / Notices
jlentini on PROD1PC65 with NOTICES
Individuals who plan to attend and
need special assistance, such as
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: September 19, 2007.
Open: 8:30 a.m. to 12 p.m.
Agenda: To present the Director’s Report
and other scientific presentations.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference E1/E2, Bethesda, MD 20892.
Closed: 4:15 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference E1/E2, Bethesda, MD 20892.
Open: 4:30 p.m. to 5:30 p.m.
Agenda: Continuation of the Director’s
Report and other scientific presentations.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference E1/E2, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council, Diabetes, Endocrinology, and
Metabolic Diseases Subcommittee.
Date: September 19, 2007.
Closed: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference E1/E2, Bethesda, MD 20892.
Open: 2:30 p.m. to 4 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference E1/E2, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council, Digestive Diseases and Nutrition
Subcommittee.
VerDate Aug<31>2005
15:56 Aug 06, 2007
Jkt 211001
Date: September 19, 2007.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Room D, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Room D, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive,
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 584–8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council, Kidney, Urologic, and Hematologic
Diseases Subcommittee.
Date: September 19, 2007.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Room F1/F2, Bethesda, MD
20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Room F1/F2, Bethesda, MD
20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892,
(301) 594–8843, stanfibr@niddk.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www.niddk.nih.gov/fund/divisions/DEA/
Council/coundesc.htm., where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
44167
Dated: July 31, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–3848 Filed 8–6–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Host Response to
Francisella Tularensis.
Date: August 27, 2007.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Room 4200, Bethesda, MD 20817 (Telephone
Conference Call).
Contact Person: Lynn Rust, PhD, Scientific
Review Administrator, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, Room 3120, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892, (301) 402–3938, lr228v@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transportation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 31, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–3849 Filed 8–6–07; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\07AUN1.SGM
07AUN1
]]>Agencies
[Federal Register Volume 72, Number 151 (Tuesday, August 7, 2007)]
[Notices]
[Pages 44166-44167]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-3848]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of
the National Diabetes and Digestive and Kidney Diseases Advisory
Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available.
[[Page 44167]]
Individuals who plan to attend and need special assistance, such as
language interpretation or other reasonable accommodations, should
notify the Contact Person listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council.
Date: September 19, 2007.
Open: 8:30 a.m. to 12 p.m.
Agenda: To present the Director's Report and other scientific
presentations.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Conference E1/E2, Bethesda, MD 20892.
Closed: 4:15 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Conference E1/E2, Bethesda, MD 20892.
Open: 4:30 p.m. to 5:30 p.m.
Agenda: Continuation of the Director's Report and other
scientific presentations.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Conference E1/E2, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division of
Extramural Activities, National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council, Diabetes, Endocrinology, and Metabolic
Diseases Subcommittee.
Date: September 19, 2007.
Closed: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Conference E1/E2, Bethesda, MD 20892.
Open: 2:30 p.m. to 4 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Conference E1/E2, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council, Digestive Diseases and Nutrition
Subcommittee.
Date: September 19, 2007.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Conference Room D, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Conference Room D, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division of
Extramural Activities, National Institutes of Diabetes and
Digestive, and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC
5452, Bethesda, MD 20892, (301) 584-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council, Kidney, Urologic, and Hematologic
Diseases Subcommittee.
Date: September 19, 2007.
Open: 1 p.m. to 2:30 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Conference Room F1/F2, Bethesda, MD 20892.
Closed: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Conference Room F1/F2, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD, Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd., Room 715, MSC 5452,
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.htm.,
where an agenda and any additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: July 31, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-3848 Filed 8-6-07; 8:45 am]
BILLING CODE 4140-01-M
